$QNCX
Quince Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is QNCX up today? It is at $33.93 (+5.67%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment QNCX spikes, and full due diligence on QNCX — key stats, earnings, dilution and insider activity. Free.
Get free $QNCX alerts the moment volume spikes
Our scanner flagged $QNCX 2 times in the last 30 days. Create a free account to track $QNCX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $33.93
- Change today
- +5.67%
- Previous close
- $32.11
- 52-week range
- $0.790 – $45.50
- Market cap
- $35M
- Institutional own.
- 33.49%
- Total held
- 36.8%
- Tradeable float
- 643K 63% of shares · after 3% insiders + 33% institutions
- Short interest
- 57K ▲ +12% vs prior · as of 2026-07-31
- Short % of float
- 8.8%
- Days to cover
- 1.5d
- Avg daily volume
- 2.9M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.2x
- 15m
- 0.2x
- 1h
- 0.2x
- 1D
- --
Get free QNCX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $QNCX up today?
Here is the latest on QNCX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QNCX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $QNCX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$QNCX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$QNCX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to QNCX
Comparable names in biological products, (no diagnostic substances), closest in size first.
QNCX stock FAQ
Why is $QNCX up today?
Here is the latest on QNCX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for QNCX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the QNCX stock price today?
QNCX last traded at $33.93, up 5.67% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live QNCX alerts?
The QNCX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged QNCX 2 times in the last 30 days.
What exchange is QNCX on?
QNCX (Quince Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $35M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is QNCX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge QNCX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.